UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Immunomodulation neuroprotection and remyelination – The fundamental therapeutic effects of glatiramer acetate: A critical review

Journal of autoimmunity, 2014-11, Vol.54, p.81-92

Aharoni, Rina

2014

Volltextzugriff (PDF)

Astrocytes in Multiple Sclerosis—Essential Constituents with Diverse Multifaceted Functions

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5904

2021

Volltextzugriff (PDF)

The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5

Nature communications, 2021-03, Vol.12 (1), p.1893-1893, Article 1893

2021

Volltextzugriff (PDF)

Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis

Glia, 2018-05, Vol.66 (5), p.1098-1117

2018

Volltextzugriff (PDF)

Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate

Scientific reports, 2019-03, Vol.9 (1), p.4140, Article 4140

2019

Volltextzugriff (PDF)

Astrocyte morphology is confined by cortical functional boundaries in mammals ranging from mice to human

eLife, 2016-06, Vol.5

2016

Volltextzugriff (PDF)

Mechanism of Action of Glatiramer Acetate in Multiple Sclerosis and Its Potential for the Development of New Applications

Proceedings of the National Academy of Sciences - PNAS, 2004-10, Vol.101 (Suppl 2), p.14593-14598

2004

Volltextzugriff (PDF)

Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13419

2021

Volltextzugriff (PDF)

The mechanism of action of glatiramer acetate in multiple sclerosis and beyond

Autoimmunity reviews, 2013-03, Vol.12 (5), p.543-553

Aharoni, Rina

2013

Volltextzugriff (PDF)

Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate

Journal of Neural Transmission, 2009-11, Vol.116 (11), p.1443-1449

2009

Volltextzugriff (PDF)

Neurogenesis and Neuroprotection Induced by Peripheral Immunomodulatory Treatment of Experimental Autoimmune Encephalomyelitis

The Journal of neuroscience, 2005-09, Vol.25 (36), p.8217-8228

2005

Volltextzugriff (PDF)

Chromatin conformation governs T-cell receptor Jβ gene segment usage

Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (39), p.15865-15870

2012

Volltextzugriff (PDF)

The Immunomodulator Glatiramer Acetate Augments the Expression of Neurotrophic Factors in Brains of Experimental Autoimmune Encephalomyelitis Mice

Proceedings of the National Academy of Sciences - PNAS, 2005-12, Vol.102 (52), p.19045-19050

2005

Volltextzugriff (PDF)

Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate

Journal of autoimmunity, 2011-11, Vol.37 (3), p.228-241

2011

Volltextzugriff (PDF)

Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

Proceedings of the National Academy of Sciences - PNAS, 2008-08, Vol.105 (32), p.11358-11363

2008

Volltextzugriff (PDF)

Glatiramer Acetate-Specific T Cells in the Brain Express T Helper 2/3 Cytokines and Brain-Derived Neurotrophic Factor in situ

Proceedings of the National Academy of Sciences - PNAS, 2003-11, Vol.100 (24), p.14157-14162

2003

Volltextzugriff (PDF)

Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate

Experimental neurology, 2013-02, Vol.240, p.130-144

2013

Volltextzugriff (PDF)

Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders

Molecular neurobiology, 2007-12, Vol.36 (3), p.245-253

2007

Volltextzugriff (PDF)

Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis

Frontiers in chemistry, 2022-06, Vol.10, p.885180-885180

2022

Volltextzugriff (PDF)

Specific Th2 Cells Accumulate in the Central Nervous System to Mice Protected against Experimental Autoimmune Encephalomyelitis by Copolymer 1

Proceedings of the National Academy of Sciences - PNAS, 2000-10, Vol.97 (21), p.11472-11477

2000

Volltextzugriff (PDF)

Copolymer 1 Induces T Cells of the T Helper Type 2 that Crossreact with Myelin Basic Protein and Suppress Experimental Autoimmune Encephalomyelitis

Proceedings of the National Academy of Sciences - PNAS, 1997-09, Vol.94 (20), p.10821-10826

1997

Volltextzugriff (PDF)

Glatiramer Acetate: from Bench to Bed and Back

The Israel Medical Association journal, 2019-03, Vol.21 (3), p.151-157

2019

Volltextzugriff (PDF)

Remyelination in multiple sclerosis: realizing a long-standing challenge

Expert review of neurotherapeutics, 2015-12, Vol.15 (12), p.1369-1372

Aharoni, Rina

2015

Volltextzugriff (PDF)

Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease

The Journal of pharmacology and experimental therapeutics, 2006-07, Vol.318 (1), p.68

2006

Volltextzugriff (PDF)

Copolymer 1 Acts Against the Immunodominant Epitope 82-100 of Myelin Basic Protein by T Cell Receptor Antagonism in Addition to Major Histocompatibility Complex Blocking

Proceedings of the National Academy of Sciences - PNAS, 1999-01, Vol.96 (2), p.634-639

1999

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(75)
Buchkapitel
(2)

Sprache

Englisch
(77)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Animals
(52)
Life Sciences & Biomedicine
(46)
Mice
(46)
Multiple Sclerosis
(36)
Glatiramer Acetate
(34)
Immunology
(31)
Experimental Autoimmune Encephalomyelitis
(29)
Encephalomyelitis, Autoimmune, Experimental - Immunology
(25)
Humans
(25)
Mice, Inbred C57bl
(22)
Female
(20)
Encephalomyelitis, Autoimmune, Experimental - Drug Therapy
(19)
Neurosciences & Neurology
(18)
Neuroprotection
(17)
Neurosciences
(17)
Immunomodulation
(16)
Mice, Inbred Balb C
(16)
Multidisciplinary Sciences
(16)
Multiple Sclerosis - Immunology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunomodulation neuroprotection and remyelination – The fundamental therapeutic effects of glatiramer acetate: A critical review

Astrocytes in Multiple Sclerosis—Essential Constituents with Diverse Multifaceted Functions

The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5

Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis

Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate

Astrocyte morphology is confined by cortical functional boundaries in mammals ranging from mice to human

Mechanism of Action of Glatiramer Acetate in Multiple Sclerosis and Its Potential for the Development of New Applications

Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis

The mechanism of action of glatiramer acetate in multiple sclerosis and beyond

Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate

Neurogenesis and Neuroprotection Induced by Peripheral Immunomodulatory Treatment of Experimental Autoimmune Encephalomyelitis

Chromatin conformation governs T-cell receptor Jβ gene segment usage

The Immunomodulator Glatiramer Acetate Augments the Expression of Neurotrophic Factors in Brains of Experimental Autoimmune Encephalomyelitis Mice

Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate

Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

Glatiramer Acetate-Specific T Cells in the Brain Express T Helper 2/3 Cytokines and Brain-Derived Neurotrophic Factor in situ

Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate

Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders

Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis

Specific Th2 Cells Accumulate in the Central Nervous System to Mice Protected against Experimental Autoimmune Encephalomyelitis by Copolymer 1

Copolymer 1 Induces T Cells of the T Helper Type 2 that Crossreact with Myelin Basic Protein and Suppress Experimental Autoimmune Encephalomyelitis

Glatiramer Acetate: from Bench to Bed and Back

Remyelination in multiple sclerosis: realizing a long-standing challenge

Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease

Copolymer 1 Acts Against the Immunodominant Epitope 82-100 of Myelin Basic Protein by T Cell Receptor Antagonism in Addition to Major Histocompatibility Complex Blocking

Suchergebnisse filtern